A blood test has been created that can predict whether we will die in the next 5-10 years
Would you like to know when your last hour will sound, or maybe you assume that it is better not to know it? In any case, the latest research suggests that we will soon be able to check it.
New provocative studies suggest that thanks to blood tests we are able to track 14 different biomarkers that are able to predict the risk of death in the next ten years much more effectively than other available methods (of course, as you can guess, the clinical tests of this solution are still far away dear, but its authors are of good cheer). Interestingly, these markers are not associated with any particular disease and relate to mortality from all causes – they represent general health, monitoring e.g. inflammation or glycolysis.
Scientists have already conducted tests on a group of 44,000 patients from all age groups, which has allowed them to prove that the method is equally effective regardless of age or gender techguides. However, the research had its limitations and, for example, mainly Europeans took part in them, so now you will have to spend a lot of time to supplement the data with other ethnic groups in which the results may be completely different. In addition, we must remember that we are not just talking about a certain whim or knowledge for the sake of knowledge, because these tests can find practical medical application.
And we’re talking about the so-called surrogate endpoint, i.e. a measurable change in the state of health assessed in a clinical trial that is the result of therapeutic, prophylactic or exposure intervention. The surrogate endpoints can measure parameters that correlate with disease progression or extent, and their main goal is to obtain a conclusion without observation of significant endpoints, which often require years of observation, a large group of patients, and large financial outlays. As an example, for example, bone mineral density can be measured instead of the risk of fracture in the prevention of osteoporosis.
One of the authors of the study, Eline Slagboom from Leiden University, also suggests that the new method may help doctors determine more effective ways to treat older patients: – Calendar age does not say much about the general health of the elderly, because one 70-year-old can healthy as a fish, and another suffer from three different diseases. Now we have a set of biomarkers that will help us identify weaker patients who need help in the first place.